The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials (Q38593722)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 September 2015

Language	Label	Description	Also known as
English	The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials	scientific article published on 25 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials (English)

1 reference

Europe PubMed Central

4 September 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Gabriella Passacquale

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Paolo Di Giosia

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 September 2015

1 reference

Europe PubMed Central

4 September 2017

Cardiovascular Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

109

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

9-23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Anti-inflammatory therapies for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatment

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Monocytes in coronary artery disease and atherosclerosis: where are we now?

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Inflammatory biomarkers for predicting cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Comparison of gene expression profiles between human and mouse monocyte subsets

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Monocyte and macrophage heterogeneity

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Fractalkine preferentially mediates arrest and migration of CD16+ monocytes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Macrophage plasticity in experimental atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Blood monocytes consist of two principal subsets with distinct migratory properties

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

C-reactive Protein among Community-Dwelling Hypertensives on Single-agent Antihypertensive Treatment

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The safety and immunogenicity of a CETP vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Co-administration of a CpG adjuvant (VaxImmune, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Heat shock protein 60 and immune inflammatory responses in atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Identifiers

10.1093/CVR/CVV227

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38593722&oldid=1769238216"